LEO Pharma 

NOTE: IAPO is in no way responsible for the content of the Industry Partner profiles.  These have been produced using information provided by the Industry Partners.

LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit.

Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.

LEO Pharma is headquartered in Denmark with a global team of 6,000 people, serving 92 million patients in 130 countries. In 2019, the company generated net sales of EUR 1,447 million. For more information please visit www.leo-pharma.com.